Liat Hadad Simhayoff
Profile
Ms. Liat H.
Simhayoff is Chief Financial Officer at Hadasit Bio-Holdings Ltd., VP-Business Development & Marketing at Israel Biomedical Innovations Ltd., and VP-Marketing & Business Development at Allium Medical Solutions Ltd.
She is on the Board of Directors at Tikcro Technologies Ltd.
She received her undergraduate degree from Tel-Aviv University, an undergraduate degree from The Open University, and an MBA from Tel-Aviv University.
Former positions of Liat Hadad Simhayoff
| Companies | Position | End |
|---|---|---|
| ALLMED SOLUTIONS LTD | Sales & Marketing | - |
| HBL - HADASIT BIO-HOLDINGS LTD | Director of Finance/CFO | - |
| TIKCRO TECHNOLOGIES LTD. | Director/Board Member | - |
I.B.I Israel Biomedical Innovations Ltd.
 I.B.I Israel Biomedical Innovations Ltd. Medical SpecialtiesHealth Technology I.B.I Israel Biomedical Innovations Ltd. provides surgical and medical solutions specifically for gynecology, urology and gastroenterology. The company was founded in 2004 and is headquartered in Haogen, Israel. | Sales & Marketing | - |
Training of Liat Hadad Simhayoff
| Tel-Aviv University | Masters Business Admin |
| The Open University | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 2 |
|---|---|
| HBL - HADASIT BIO-HOLDINGS LTD | Finance |
| ALLMED SOLUTIONS LTD | Health Technology |
| Private companies | 2 |
|---|---|
I.B.I Israel Biomedical Innovations Ltd.
I.B.I Israel Biomedical Innovations Ltd. Medical SpecialtiesHealth Technology I.B.I Israel Biomedical Innovations Ltd. provides surgical and medical solutions specifically for gynecology, urology and gastroenterology. The company was founded in 2004 and is headquartered in Haogen, Israel. | Health Technology |
Tikcro Technologies Ltd.
 Tikcro Technologies Ltd. BiotechnologyHealth Technology Tikcro Technologies Ltd. operates as a biopharmaceutical company. It pursues an early stage biotechnology project generating new antibodies for cancer treatment addressing immune modulation. This project is based on technology from the Weizmann Institute of Science in Israel. It promotes a new approach for the generation of antibodies which are expected to have selectivity and blocking capabilities and, as a result, are expected to effectively modulate the immune system. Tikcro Technologies was founded on December 14, 1999 and is headquartered in Hadera, Israel. | Health Technology |
- Stock Market
- Insiders
- Liat Hadad Simhayoff
